Document Detail

Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury following acute myocardial ischemia in cats.
MedLine Citation:
PMID:  2929397     Owner:  NLM     Status:  MEDLINE    
The ability of BM-13505, 4-[2-(4-chlorobenzenesulfonylamino) ethyl]-benzene acetic acid), a specific thromboxane/endoperoxide receptor antagonist, to protect the myocardium against ischemia and reperfusion injury, was assessed in an anesthetized cat model. Cats were rendered ischemic by left anterior descending (LAD) coronary artery ligation for 1 1/2 hours followed by reperfusion for 4 1/2 hours. BM-13505 or its vehicle (i.e., Na2CO3) was administered intravenously 30 minutes before reperfusion at a rate of 1 mg/kg followed by 1 mg/kg/hr. BM-13505 significantly (p less than 0.001) reduced the area of ischemic tissue as a percent of total left ventricular mass and total area at risk, without altering basic hemodynamics (i.e., arterial blood pressure, heart rate, or their product) and thereby not influencing myocardial oxygen demand. The mechanism of the protective effect of the thromboxane receptor antagonist appears to be cytoprotective but may involve the prevention of neutrophil-induced cellular damage.
A M Bhat; H Sacks; J A Osborne; A M Lefer
Related Documents :
7586447 - Supplement of nitric oxide attenuates neutrophil-mediated reperfusion injury.
8343327 - A patient in whom self-terminating ventricular fibrillation was a manifestation of myoc...
8252597 - Lack of myocardial lipid peroxidation during acute reperfusion injury in perfused guine...
20652807 - 99mtc-glucarate kinetics differentiate normal, stunned, hibernating, and nonviable myoc...
15523547 - Myocardial revascularisation in patients with severe left ventricular dysfunction. earl...
20346327 - Pitfalls in the diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  American heart journal     Volume:  117     ISSN:  0002-8703     ISO Abbreviation:  Am. Heart J.     Publication Date:  1989 Apr 
Date Detail:
Created Date:  1989-05-03     Completed Date:  1989-05-03     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  799-803     Citation Subset:  AIM; IM    
Department of Physiology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Disease
Blood Pressure / drug effects
Coronary Disease / enzymology,  physiopathology*
Creatine Kinase / blood
Heart Rate / drug effects
Myocardial Reperfusion Injury / pathology,  prevention & control*
Myocardium / pathology
Phenylacetates / therapeutic use*
Sulfonamides / therapeutic use*
Thromboxanes / antagonists & inhibitors*
Grant Support
Reg. No./Substance:
0/Phenylacetates; 0/Sulfonamides; 0/Thromboxanes; 105218-03-9/daltroban; EC Kinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Improvement in functional recovery of stunned canine myocardium by long-term pretreatment with oral ...
Next Document:  Relationship of functional recovery to scar contraction after myocardial infarction in the canine le...